Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus

[1]  D. M. Abd El Motteleb,et al.  Vitamin K2 alleviates type 2 diabetes in rats by induction of osteocalcin gene expression. , 2018, Nutrition.

[2]  P. Winocour Diabetes and chronic kidney disease: an increasingly common multi‐morbid disease in need of a paradigm shift in care , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[3]  J. Starup-Linde,et al.  Diabetes and Abdominal Aortic Calcification—a Systematic Review , 2018, Current Osteoporosis Reports.

[4]  N. Suksomboon,et al.  Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis , 2017, Diabetes, metabolic syndrome and obesity : targets and therapy.

[5]  M. Cohen-Solal,et al.  Evaluation of fracture risk in chronic kidney disease , 2017, Journal of Nephrology.

[6]  P. Stenvinkel,et al.  Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis , 2017, Journal of Nephrology.

[7]  M. Urashima,et al.  Role of vitamin D in diabetes mellitus and chronic kidney disease. , 2016, World journal of diabetes.

[8]  A. Santoro,et al.  Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients , 2016, Journal of Nephrology.

[9]  S. Giannini,et al.  Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins , 2016, Endocrine.

[10]  S. Giannini,et al.  Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. , 2015, Current vascular pharmacology.

[11]  The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients , 2014, Clinical chemistry and laboratory medicine.

[12]  F. Cantatore,et al.  Osteocalcin: Skeletal and extra‐skeletal effects , 2013, Journal of cellular physiology.

[13]  R. Nuti,et al.  Endocrine Actions of Osteocalcin , 2013, International journal of endocrinology.

[14]  J. Goudable,et al.  Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  S. Giannini,et al.  Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  H. Choi,et al.  Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial , 2011, Diabetes Care.

[17]  J. Bacchetta,et al.  The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  H. Xie,et al.  Development of Arterial Calcification in Adiponectin‐Deficient Mice: Adiponectin Regulates Arterial Calcification , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  L. Schurgers,et al.  Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  L. Schurgers,et al.  The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification , 2008, Journal of Vascular Research.

[21]  G. Karsenty,et al.  Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice , 2008, Proceedings of the National Academy of Sciences.

[22]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[23]  M. Shearer,et al.  Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification , 2000, Current opinion in clinical nutrition and metabolic care.

[24]  D. E. Grobbee,et al.  J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis , 1994, The Lancet.